Chadé Severin

Ms. Severin was named a winner in the New Leaders in the Law category of the 2024 New England Legal Awards, and named among Law360’s 2021 Rising Stars, which recognizes top “attorneys under 40 whose legal accomplishments transcend their age.” Her representations include:

• AspenTech in its $11 billion combination with the industrial software business of Emerson Electric
• Ambrx Biopharma in its $2 billion acquisition by Johnson & Johnson
• POINT Biopharma in its $1.4 billion acquisition by Eli Lilly
• Adtalem Global Education in the $1 billion sale of its financial services segment to a consortium of Wendel Group and Colibri Group
• Strongbridge Biopharma in its sale to Xeris Pharmaceuticals for $267 million
• Pandion Therapeutics in its sale to Merck & Co. for $1.85 billion
• Stemline Therapeutics in its sale to Menarini Group for up to $677 million
• Gilead Sciences in its $4.9 billion acquisition of Forty Seven
• ArQule in its sale to Merck for $2.7 billion
• Carbonite in its sale to OpenText for $1.42 billion
• Achillion in its sale to Alexion for up to $1.225 billion
• Alder BioPharmaceuticals in its sale to Lundbeck for up to $1.95 billion
• Array BioPharma in its $11.4 billion sale to Pfizer
• Carbonite in its $618.5 million acquisition of Webroot
• Armstrong Flooring Inc. in the sale of its wood flooring business to American Industrial Partners
• Juno Therapeutics in its $9 billion acquisition by Celgene
• Ultragenyx in its successful topping bid for Dimension Therapeutics
• Gilead in its $11.9 billion acquisition of Kite Pharma
• Merrimack Pharmaceuticals in its asset sale to Ipsen S.A. for up to $1.025 billion
• Tobira Therapeutics in its acquisition by Allergan for up to $1.7 billion
• Qlik Technologies in its $3 billion acquisition by Thoma Bravo

Before attending law school, Ms. Severin worked for Google at its California headquarters.